Comments to FDA: Developing Nicotine Replacement Therapy Drug Products

Docket Number:

FDA-2019-D-0297

CHPA welcomes the opportunity to comment on the draft guidance on indications for nicotine replacement therapies (NRT).

Issues:

OTC Medicines